Extracorporeal shockwave therapy devices for musculoskeletal pain, plantar fasciitis, tendinopathies, and ED. Both radial and focused variants. Used across physical therapy, orthopedics, sports medicine, urology, and podiatry.
Extracorporeal shockwave therapy delivers high-energy acoustic waves to musculoskeletal tissue. Two variants exist. Focused shockwave (ESWT) uses electromagnetic, electrohydraulic, or piezoelectric generation to focus energy at depth (4-12cm), reaching deep tendons and bone-tendon junctions. Radial pressure wave (RPW) generates pneumatic shockwaves that disperse near the surface, treating superficial trigger points and fascia. Focused has stronger evidence for calcific tendinitis and deep tendinopathies. Radial is faster, cheaper, and easier to operate.
Shockwave therapy is dominated by a small group of European manufacturers. Storz Medical (Switzerland) makes the DUOLITH and MASTERPULS lines, both reference-standard platforms in clinical research. EMS Electro Medical Systems makes the Swiss DolorClast. Chattanooga (Enovis) leads in US PT clinics with its RPW platform. SoftWave (TRT) has gained traction in chiropractic and sports medicine with its unfocused planar shockwave.
The category is being transformed by ED indications. The off-label use of focused shockwave for erectile dysfunction has created a parallel market that didn't exist five years ago. Urology and men's health clinics are buying focused shockwave platforms at $80K-$120K specifically for ED treatments billed at $300-$500 per session. PT clinics are seeing competition from cheaper Chinese imports priced under $20K. The reference-standard manufacturers are responding with bundled training and software upgrades to defend pricing.
Physical therapy clinics, orthopedic and sports medicine practices, podiatry, and increasingly urology and men's health. The buyer profile is bifurcating. PT clinics want radial shockwave for general MSK work at $15K-$40K. Urology and sports medicine want focused shockwave for ED and deep tendinopathies at $60K-$120K. Chiropractic has emerged as a meaningful third buyer segment.
A starting point: MASTERPULS MP200
MASTERPULS MP200 (Storz Medical) is the first published profile in this category to review, not a claim that it is best for every practice. Physical therapy, chiropractic, and sports medicine practices that need radial shockwave at a moderate capital cost. Practices building a dedicated shockwave service line without the premium of combined focused-plus-radial.
Review its documented capabilities and limits, then compare them with your indication, patient mix, service requirements, and written quote. 50+ published studies. Reference platform in much of the European shockwave literature.
One tradeoff to test: Radial only (no focused shockwave capability for deep targets). Device Pulse does not treat manufacturer coverage, listing order, or a clearance record as proof of comparative superiority.
Physical therapy, chiropractic, and sports medicine practices that need radial shockwave at a moderate capital cost. Practices building a dedicated shockwave service line without the premium of combin
Sports medicine practices and orthopedic clinics that want the most versatile shockwave platform. Practices that see complex tendinopathies requiring focused therapy.
Academic sports medicine programs, high-volume physical therapy clinics, and research-oriented practices that need to reference peer-reviewed evidence when defending purchase decisions internally. Pra
Chiropractic, regenerative medicine, and integrative practices that can charge premium cash-pay pricing and want territory scarcity from SoftWave TRT's authorized-practice model. Practices whose patie
Physical therapy clinics that want entry-level radial shockwave capability with familiar Chattanooga service and training. Practices adding shockwave to an existing Chattanooga equipment stack.
Device selection in this category breaks into six decision factors that matter more than the specs on a sales sheet. Practices that get the selection right match the device to their specific economics rather than buying the platform with the best marketing.
Practice type considerations. Dermatologists, plastic surgeons, med spas, and multi-specialty practices have different priorities. Specialty practices weight clinical evidence heavily. Cash-pay med spas weight throughput and patient demand. Multi-specialty groups weight integration with existing platforms. Start here before looking at any individual device.
Patient demographics. Skin type range, age distribution, average household income, and willingness to pay per-session pricing all affect which device fits. Markets with price-sensitive patients need different devices than concierge practices. Run a realistic patient persona before evaluating specific platforms.
Budget scope. Set a practice-specific capital ceiling, then compare the full five-year obligation: financing, software, accessories, consumables, service, staffing, downtime, and exit terms. Do not infer demand from the size of the purchase.
New vs used and refurbished. Compare exact configurations and written terms. Verify title, software eligibility, service history, transfer fees, warranty, parts, training, and inspection results before treating a lower used asking price as savings.
Consumables and operating costs. Request a current itemized schedule for consumables, software, preventive maintenance, repairs, and required accessories. Model those costs at the practice's measured volume.
Clinical evidence requirements and device ecosystem fit. Academic and research-oriented practices weight evidence quality heavily. High-volume cash-pay practices weight brand recognition. Existing device ecosystems create cross-sell and training efficiencies that often tilt the decision toward one manufacturer over another.
Focused vs radial (depth and indication coverage)
Reimbursement plan (cash-pay vs insurance billing)
Patient mix (deep tendons vs surface trigger points)
Operator training and certification requirements
Service contract and parts availability in your region
Cash-pay ED program viability in your market
Market Trends
New equipment pricing has held steady at the premium tier. Storz DUOLITH still commands $80K-$120K. Used focused shockwave systems trade at $30K-$60K. The growth area is cash-pay ED programs, which have transformed shockwave from a PT capital expense into a revenue-generating men's health service line. Chinese imports continue to pressure the low end of the radial market. Sales reps for premium brands now lead with clinical evidence and training rather than feature comparisons.
Current FDA records can show clearance scope, recalls, and other regulatory activity, but they do not establish comparative quality or future support. Before a multi-year agreement, verify the exact legal counterparty, written service obligations, parts access, software support, transfer terms, and available public filings where relevant.
Frequently Asked Questions
Which shockwave devices does Device Pulse currently cover?
Current published profiles include MASTERPULS MP200, DUOLITH SD1, Swiss DolorClast, SoftWave OrthoGold 100. This is a coverage list, not a complete market inventory or a ranking. The right short list depends on indication, patient mix, service support, evidence requirements, and verified commercial terms.
How much do shockwave devices cost?
The category record carries a legacy editorial range of $15,000-$120,000. It is not a dated sample of completed transactions. Compare current itemized quotes for the same model, configuration, software, accessories, service, training, and delivery scope.
Which specialties buy shockwave devices?
Primary buyers include Physical Therapy, Orthopedics, Sports Medicine, Urology, Podiatry. The buyer profile varies by device tier. Premium platforms go to high-volume practices with established patient flow. Mid-range platforms fit specialty practices building a new service line. Starter-tier platforms work for practices testing category demand before committing to a flagship purchase.
How fast is the shockwave market growing?
The global shockwave market is approximately $780M (2025) with 8% CAGR projected growth. Growth is not uniform across manufacturers. Category leaders typically hold or grow share while mid-tier brands compete on price and newer entrants try to win on clinical evidence or technology differentiation. Physicians making purchase decisions should weigh manufacturer momentum alongside headline market growth.
What's changing in the shockwave category right now?
The category is being transformed by ED indications. The off-label use of focused shockwave for erectile dysfunction has created a parallel market that didn't exist five years ago. Urology and men's health clinics are buying focused shockwave platforms at $80K-$120K specifically for ED treatments billed at $300-$500 per session. PT clinics are seeing competition from cheaper Chinese imports priced under $20K. The reference-standard manufacturers are responding with bundled training and software upgrades to defend pricing.
How do I choose the right shockwave device?
The decision framework for this category covers practice type, patient demographics, budget, existing device ecosystem, clinical evidence requirements, and consumable economics. Match the device to your specific practice rather than buying what a sales rep recommends as a general best choice. Our specialty guides break this down by practice type.
Are used or refurbished shockwave devices worth buying?
A used device can reduce capital cost, but the discount and risk are unit-specific. Verify serial-number history, title, software, handpieces, service records, transfer fees, warranty, parts access, and the exact cleared model before comparing a used offer with a new quote.
What are the biggest risks in buying a shockwave device?
The top risks: buying ahead of patient demand, choosing a device based on sales rep claims without independent diligence, ignoring consumable cost structures, and failing to verify manufacturer service support in your region. Physicians who project optimistic treatment volumes and finance a large purchase based on those projections often regret the decision within 18 months. Run your numbers on conservative assumptions before signing a contract.